Integration of active tuberculosis case finding in a mobile HIV-testing clinic is feasible

August 7, 2012

A research article by Katharina Kranzer from the London School of Hygiene & Tropical Medicine and colleagues describe the feasibility and costs of an active tuberculosis case finding project in Cape Town, South Africa.

The study describes the integration of tuberculosis testing into a mobile HIV testing service for HIV-negative individuals with symptoms suggestive of tuberculosis and all HIV-positive individuals.

The mobile testing clinic, named the Tutu Tester after Archbishop Emeritus Desmond Tutu, visits underserviced areas in greater Cape Town and provides testing services for deprived communities.

The study demonstrates that active tuberculosis case finding in settings with a high burden of HIV and tuberculosis is feasible and has a high uptake, yield, and treatment success. However, the authors note that further work is required to determine whether mobile case finding is cost-effective and whether the service can be scaled up.

Explore further: Study finds community counseling reduced the prevalence of TB on a budget

More information: Kranzer K, Lawn SD, Meyer-Rath G, Vassall A, Raditlhalo E, et al. (2012) Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study. PLoS Med 9(8): e1001281. doi:10.1371/journal.pmed.1001281

Related Stories

Study finds community counseling reduced the prevalence of TB on a budget

October 30, 2011
The results of a large-scale community-randomized trial presented at the 42nd World Conference on Lung Health in Lille, France today show that the Zambia-South Africa TB and AIDS Reduction (ZAMSTAR) project reduced the prevalence ...

Experimental vaccine elicits robust response against both HIV and tuberculosis

May 22, 2012
Clinician researchers in China have developed a vaccine that acts simultaneously against HIV-1 and M. tuberculosis (Mtb). An estimated 14 million people worldwide are coinfected with the two pathogens. The research is published ...

PET scans predict effectiveness of treatment for multidrug-resistant tuberculosis in HIV patients

May 24, 2011
With the deficiencies in knowledge of tuberculosis -- as well as in the practices, programs and strategies used to combat the disease and co-infection with human immunodeficiency virus (HIV) -- the spread of multidrug-resistant ...

Recommended for you

New compound stops progressive kidney disease in its tracks

December 7, 2017
Progressive kidney diseases, whether caused by obesity, hypertension, diabetes, or rare genetic mutations, often have the same outcome: The cells responsible for filtering the blood are destroyed. Reporting today in Science, ...

New Lyme disease tests could offer quicker, more accurate detection

December 7, 2017
New tests to detect early Lyme disease - which is increasing beyond the summer months -could replace existing tests that often do not clearly identify the infection before health problems occur.

Spinal tap needle type impacts the risk of complications

December 6, 2017
The type of needle used during a lumbar puncture makes a significant difference in the subsequent occurrence of headache, nerve irritation and hearing disturbance in patients, according to a study by Hamilton medical researchers.

Men with HPV are 20 times more likely to be reinfected after one year

December 5, 2017
A new analysis of genital human papillomavirus (HPV) in men shows that infection with one HPV type strongly increases the risk of reinfection with the same type. In fact, men who are infected with the type responsible for ...

New tuberculosis drugs possible with understanding of old antibiotic

December 5, 2017
Tuberculosis, and other life-threatening microbial diseases, could be more effectively tackled with future drugs, thanks to new research into an old antibiotic by the University of Warwick and The Francis Crick Institute.

Scientists create successful mass production system for bioengineered livers

December 5, 2017
Researchers report creating a biologically accurate mass-production platform that overcomes major barriers to bioengineering human liver tissues suitable for therapeutic transplant into people.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.